Sign in

Research summary ·

Preoperative versus postoperative single-fraction or fractionated stereotactic radiosurgery for resected brain metastases: a systematic review and network meta-analysis.

Written based on 1 research study on PubMed, searched on 15 Nov 2026.

What was studied

This study looked at cancer that has spread to the brain. In these people, the brain tumor was taken out by surgery. Focused beams of radiation, called SRS, can be given before or after surgery. SRS can also be given in one session or in several. The team pooled past studies that compared these choices, up to 12 August 2026. They also used a method that compares options never tested side by side.

What they found

The review included both randomized trials and other kinds of studies. Only a few studies could be put into one shared model. In one trial, SRS after surgery cut the risk of the tumor coming back. This was compared with just watching people without radiation. SRS before versus after surgery gave unclear results. One session versus several sessions also gave unclear results. Results on spread to the brain lining and on radiation damage could not be pooled.

What it means for patients

Trial results back SRS after surgery over just watching. It may lower the chance of the tumor coming back in that spot. But the review could not show which timing or session plan works better. The authors say choices should depend on each person's own health details. They say this holds until larger, well-planned forward-looking studies are done.

Why it is not certain yet

Each direct comparison rested on just one study. The ranges around the indirect results were wide. Some results changed based on which studies were chosen. Certainty was very low for all but one tumor-return comparison. Some included studies were not randomized. Data on brain lining spread and radiation damage were too thin to compare.

Source

Preoperative versus postoperative single-fraction or fractionated stereotactic radiosurgery for resected brain metastases: a systematic review and network meta-analysis.

PubMed · PMID 42952529

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Brain metastases publications